PROGRAF
Total Payments
$12,160
Transactions
28
Doctors
20
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $3,000 | 1 | 1 |
| 2020 | $8,633 | 5 | 0 |
| 2019 | $69.98 | 2 | 2 |
| 2018 | $457.11 | 20 | 18 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8,633 | 5 | 71.0% |
| Consulting Fee | $3,000 | 1 | 24.7% |
| Food and Beverage | $527.09 | 22 | 4.3% |
Payments by Type
Research
$8,633
5 transactions
General
$3,527
23 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| BUDGET IMPACT MODEL OF DSA FORMATION | Astellas Pharma Global Development | $8,633 | 0 |
Top Doctors Receiving Payments for PROGRAF
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Denver, CO | $8,633 | 5 |
| Chester Oddis | Specialist | Pittsburgh, PA | $3,000 | 1 |
| , M.D | Nephrology | Detroit, MI | $50.87 | 1 |
| , MD | Nephrology | Aurora, CO | $50.87 | 1 |
| , D.O | Nephrology | Boston, MA | $50.87 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Birmingham, AL | $47.11 | 1 |
| , M.D., PHD | Transplant Surgery | Houston, TX | $45.58 | 2 |
| , M.D., PH.D | Surgery | Houston, TX | $45.58 | 2 |
| , M.D | Surgery | New York, NY | $40.80 | 2 |
| , M.D., PHD | Transplant Surgery | Houston, TX | $22.89 | 1 |
| , M.D | Nephrology | Dallas, TX | $19.41 | 1 |
| , MD | Nephrology | Honolulu, HI | $15.90 | 1 |
| , M.D | Nephrology | Honolulu, HI | $15.90 | 1 |
| , M.D | Nephrology | Honolulu, HI | $15.90 | 1 |
| , M.D | Nephrology | Winston Salem, NC | $15.90 | 1 |
| , MD | Surgery | Stanford, CA | $15.90 | 1 |
| , MD | Transplant Surgery | Honolulu, HI | $15.90 | 1 |
| , MD | Nephrology | Denton, TX | $15.05 | 1 |
| , DO | Nephrology | Denton, TX | $15.05 | 1 |
| , MD | Nephrology | Denton, TX | $15.05 | 1 |
| , MD | Transplant Hepatology | Wayne, PA | $12.56 | 1 |
Ad
Manufacturing Companies
- Astellas Pharma Global Development $8,874
- Astellas Pharma Inc $3,000
- Astellas Pharma US Inc $286.57
Product Information
- Type Drug
- Total Payments $12,160
- Total Doctors 20
- Transactions 28
About PROGRAF
PROGRAF is a drug associated with $12,160 in payments to 20 healthcare providers, recorded across 28 transactions in the CMS Open Payments database. The primary manufacturer is Astellas Pharma Global Development.
Payment data is available from 2018 to 2021. In 2021, $3,000 was paid across 1 transactions to 1 doctors.
The most common payment nature for PROGRAF is "Unspecified" ($8,633, 71.0% of total).
PROGRAF is associated with 1 research study, including "BUDGET IMPACT MODEL OF DSA FORMATION" ($8,633).